Robotic Surgery Equipment Imports

Robotic surgery equipment imports classify under HTS 9018 (medical instruments) or 9022 (X-ray related equipment) depending on configuration. FDA Class II/III medical device classification. Section 232 MedTech investigation could affect this category. Most equipment manufactured in U.S. (Intuitive da Vinci) or Israel (MAKO).

This guide covers U.S. import tariff and compliance for robotic surgery equipment.

For SMB importers in this category, the practical questions are HTS classification, applicable Section 232/301/122 stacks, FTA opportunities, and regulatory overlay (FDA/USDA/EPA/CPSC where relevant).

HTS classification basics

Surgical robots HTS 9018.90.6000 (other surgical instruments). Imaging components separate HTS.

Tariff stack and rates

Base 0-3% + Section 122 (15% on non-USMCA) + potential Section 232 MedTech (TBD).

Country of origin considerations

U.S. dominant (Intuitive Surgical). Israel (Mazor – now Medtronic). Korean and EU emerging.

Regulatory overlay

FDA Class II/III medical device. 510(k) or PMA pathway. Quality System Regulation. Foreign establishment registration.

Mitigation opportunities

Intuitive da Vinci U.S.-made faces no Section 122. Israel FTA preference for MAKO-style imports.

Frequently asked questions

What is the typical effective duty rate?

Depends on origin and HTS classification. China-origin: 22-42% effective when Section 301 + Section 122 stack. USMCA-qualifying Mexican production: often 0-3%. Vietnam, India, Korea: 15-17% with Section 122.

Can I qualify under USMCA?

Possible if production occurs in U.S., Mexico, or Canada and meets rules of origin (typically 60% RVC under transaction value or 50% net cost). USMCA-qualifying goods are exempt from Section 122.

Are IEEPA refunds available?

Yes – for entries between April 5, 2025 and February 24, 2026 that paid IEEPA duty. Filed through CBP’s CAPE portal. We file claims on contingency for filings above $50k.

What about Section 232 exposure?

Specific to product type. Steel and aluminum derivatives expansion brought some downstream products into scope. Component-level analysis identifies actual coverage.

How do you help with this category?

Tariff exposure assessment ($2,500-$7,500), classification audit, USMCA qualification, refund recovery, audit response. Independent of any customs brokerage.